Pharmakon Advisors’ $450 Million Commitment to BioCryst Pharmaceuticals

Akin advised Pharmakon Advisors on the deal.Pharmakon Advisors, LP, a leading investor in non-dilutive debt for the life sciences industry, announced its $450 million financing commitment to…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now